Migraine and cluster headache - the common link

Anne Luise Vollesen, Silvia Benemei, Francesca Cortese, Alejandro Labastida-Ramírez, Francesca Marchese, Lanfranco Pellesi, Michele Romoli, Messoud Ashina, Christian Lampl, School of Advanced Studies of the European Headache Federation (EHF-SAS)

19 Citations (Scopus)
37 Downloads (Pure)

Abstract

Although clinically distinguishable, migraine and cluster headache share prominent features such as unilateral pain, common pharmacological triggers such glyceryl trinitrate, histamine, calcitonin gene-related peptide (CGRP) and response to triptans and neuromodulation. Recent data also suggest efficacy of anti CGRP monoclonal antibodies in both migraine and cluster headache. While exact mechanisms behind both disorders remain to be fully understood, the trigeminovascular system represents one possible common pathophysiological pathway and network of both disorders. Here, we review past and current literature shedding light on similarities and differences in phenotype, heritability, pathophysiology, imaging findings and treatment options of migraine and cluster headache. A continued focus on their shared pathophysiological pathways may be important in paving future treatment avenues that could benefit both migraine and cluster headache patients.

Original languageEnglish
Article number89
JournalJournal of Headache and Pain
Volume19
Issue number1
Pages (from-to)1-15
ISSN1129-2369
DOIs
Publication statusPublished - 21 Sept 2018

Keywords

  • Calcitonin Gene-Related Peptide/antagonists & inhibitors
  • Cluster Headache/blood
  • Deep Brain Stimulation/statistics & numerical data
  • Humans
  • Implantable Neurostimulators/statistics & numerical data
  • Migraine Disorders/blood
  • Nitroglycerin/adverse effects
  • Tryptamines/pharmacology

Fingerprint

Dive into the research topics of 'Migraine and cluster headache - the common link'. Together they form a unique fingerprint.

Cite this